The dietary reference levels for vitamin D were established with an emphasis on its role in bone health; however, with the identification of vitamin D receptors in all body tissues novel associations with other metabolic disorders, such as diabetes, are being researched. Aside from its standard function as the main regulator of calcium absorption, vitamin D also controls the calcium pool, mediates the activity of beta cell calcium-dependent endopeptidases, encourages the conversion of proinsulin to insulin, increases insulin output, and raises insulin activity in peripheral insulin target tissues. Both immune cells and pancreatic beta cells include vitamin D receptors. A deficiency of vitamin D causes glucose intolerance and affects insulin secretion. Different pathogenic characteristics of the disease are linked to a number of vitamin D-related genes. It has been proven that vitamin D supplementation lowers the risk of type 1 and type 2 diabetes and its associated problems. In this article, we discussed a few prospective clinical trials on vitamin D that are necessary to clearly demonstrate the role of vitamin D in the prevention and management of diabetes.
In order to define and accomplish learning outcomes in higher education, this study investigates the idea of transdisciplinary learning and its consequences. It explores how transdisciplinary techniques might improve students critical thinking, creativity, and problem-solving abilities by drawing on theoretical frameworks and practical data. It also discusses challenges and opportunities associated with implementing transdisciplinary approaches in higher education, including issues related to curriculum design, assessment methods, and institutional support structures. It highlights examples of successful transdisciplinary initiatives from various educational. This proposed book chapter seeks to explore the significance of transdisciplinary approaches in shaping learning outcomes in higher education settings. By offering insights into the theoretical foundations and practical implications of transdisciplinary approaches to learning outcomes, it aims to contribute ongoing discussions and debates surrounding curriculum development and educational innovation in higher education.
1 July 2023 in Future Journal of Pharmaceuticals and Health Sciences
Herbal medicines are used for their safety, efficacy, cultural acceptability and lesser side effects. The chemical constituents present in plants are a part of the physiological functions of living system and hence they are believed to have better compatibility with the human body. These drugs are made from renewable resources of raw materials by eco-friendly processes and will bring economic prosperity. An herb is a plant or plant part used for its scent, flavor, or therapeutic properties. They are sold as tablets, capsules, powders, teas, extracts, and fresh or dried plants. People use herbal medicines to try to maintain or improve their health. Products made from botanicals, or plants, that are used to treat diseases or to maintain health are called herbal products, botanical products, or phytomedicines. A product made from plants and used solely for internal use is called an herbal supplement.
1 January 2025 in Future Journal of Pharmaceuticals and Health Sciences
An individual with Alzheimer's disease (AD) experiences cognitive decline, memory loss, and behavioral abnormalities. The complex condition known as AD is brought on by acetylcholinesterase (AChE), which breaks down acetylcholine. The current investigation aimed to evaluate synthetic AChE inhibitors that may be utilized to treat AD. To do this, synthetic two amino five substituted oxadiazole derivative compounds (1a - 5e) were assessed and shown to be potential AChE inhibitors, with IC50 values ranging from 7 3 ± 0.67 to 98 ± 0.7 μmol/min/mg of tissue. In silico docking investigations were performed using Schrodinger, revealing that most of the compounds are held together by π – π and hydrogen bonding and interact with the anionic subsite of AChE. Chem Bio Draw Ultra 12.0 (www.cambridgesoft.com) was used to create the 2D structures of each drug. 2. The RSC PDB (www.rscb.org) provided the crystallographic three - dimensional structure of AChE target receptors, with PDB ID: 4EY5 &604 w for AChE. The most potent compound is 5e; consequently, these compounds can potential ly be used as therapeutic agents to treat AD and its related conditions because of their AChE inhibitory capacity cytotoxicity safe profile.
2 January 2026 in Asian Journal of Chemical Sciences
Fluorine ions have transformed the manufacturing of modern medications and continue to dramatically change the physical, pharmacokinetic, and pharmacodynamic properties of drugs. The physical properties of carbon-fluorine bonds are unique due to the very high bond dissociation energy of this bond, and the fact that fluorine is a highly electronegative atom with minimal steric interference from bonding to a carbon atom, provide chemists with an opportunity to precisely modify the molecular properties of drugs without changing the overall framework of the molecule. Based on the above characteristics of C-F bonds, strategic fluorine incorporation into many biologically active molecules increases the molecules' lipophilicity, membrane permeability, metabolic stability, and resistance to enzymatic degradation, and therefore increases the bioavailability and half-life duration in vivo of those molecules. There is also a significant body of knowledge that demonstrates substituting fluorine atoms in drug molecules impacts the electronic distribution, conformation, and intermolecular interactions of those molecules, resulting in increased affinity and selectivity towards their intended targets. This review presents and discusses the influence of fluorine in drug design and highlights the influence of fluorine on molecular action via structural activity relationships as well as the method of synthesizing fluorinated drug molecules. Representative patient-indicated and commercially available fluorinated drug examples that have been clinically approved include fluoroquinolone antibiotics and fluorinated steroids used in the treatment of cancer, neurological, infectious, and cardiovascular diseases. The review additionally provides a discussion of emerging methodologies that utilize novel electrophilic and nucleophilic fluorination reagents, late stage fluorination strategies, and the incorporation of trifluoromethyl or perfluoroalkyl groups into drug structures for optimization of pharmacokinetic properties In summary, this review illustrates how the strategic fluorination is a key component of the expanded utility of chemical compounds to develop new drugs.
One of the hottest areas that opens up is at the junction of CRISPR technology and microbiome-based therapeutics in the rapidly growing horizon of medical research. This ranges from some genetic diseases to chronic diseases influenced by microbial communities and, therefore, holds much promise therapeutically with mechanisms of precision gene editing mediated by CRISPR-Cas9 and manipulation of the microbiome. This new technology has broken the barriers of precision genome alteration with unprecedented accuracy and efficiency for mankind, and this is something that the CRISPR-Cas9 technology goes beyond. The potential of CRISPR in terms of altering specific DNA sequences looks promising regarding the possibility of making cellular processes more effective, correcting genetic defects responsible for inherited diseases, and advancing discoveries on new medicines. Billions of bacteria live in and on part of the human body. As such, the microbiome is the central aspect of disease states and general health. Technological advances in the omics field-transcriptomics, proteomics, metabolomics, and genomes make it currently possible to offer highly detailed molecular medicine. <!----> <!----> <!----> <!---->